Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
XI’AN, China, Aug. 4 /Xinhua-PRNewswire-FirstCall/ — Huifeng Bio- Pharmaceutical Technology, Inc (BULLETIN BOARD: HFGB) , a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it will release financial results second quarter 2008 which ended June 30 on Friday, August 15, 2008, after the US markets close.
Huifeng’s earnings release and related materials will be posted on the investor’s page of the company website, http://www.hfgb.cn/ .
About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)
Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi’an, People’s Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. For more information, please visit the company’s web site at http://www.hfgb.cn/
For more information, please contact: Dan Carlson, Primary Capital LLC Email: DCarlson@PrimaryLLC.com Kelly Black, CEO Premier Media Services, Inc. Tel: +1-480-649-8224
Huifeng Bio-Pharmaceutical Technology, Inc.
CONTACT: Dan Carlson, Primary Capital LLC, DCarlson@PrimaryLLC.com;Kelly Black, CEO of Premier Media Services, Inc., +1-480-649-8224
Web Site: http://www.hfgb.cn/